Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,297

The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.

The emerging role of the Nrf2–Keap1 signaling pathway in cancer

Open access
Jaramillo, Melba C., Zhang, Donna D.·2013·Genes & Development

Abstract

The Nrf2 (nuclear factor erythroid 2 [NF-E2]-related factor 2 [Nrf2])–Keap1 (Kelch-like erythroid cell-derived protein with CNC homology [ECH]-associated protein 1) signaling pathway is one of the most important cell defense and survival pathways. Nrf2 can protect cells and tissues from a variety of toxicants and carcinogens by increasing the expression of a number of cytoprotective genes. As a result, several Nrf2 activators are currently being tested as chemopreventive compounds in clinical trials. Just as Nrf2 protects normal cells, studies have shown that Nrf2 may also protect cancer cells from chemotherapeutic agents and facilitate cancer progression. Nrf2 is aberrantly accumulated in many types of cancer, and its expression is associated with a poor prognosis in patients. In addition, Nrf2 expression is induced during the course of drug resistance. Collectively, these studies suggest that Nrf2 contributes to both intrinsic and acquired chemoresistance. This discovery has opened up a broad spectrum of research geared toward a better understanding of the role of Nrf2 in cancer. This review provides an overview of (1) the Nrf2–Keap1 signaling pathway, (2) the dual role of Nrf2 in cancer, (3) the molecular basis of Nrf2 activation in cancer cells, and (4) the challenges in the development of Nrf2-based drugs for chemoprevention and chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.225680.113

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 8

  1. 2004, Breast cancer risk in premenopausal women is inversely associated with consumption of broccoli, a source of isothiocyanates, but is not modified by GST genotype, J Nutr, 134, 1134, 10.1093/jn/134.5.1134 · doi:10.1093/jn/134.5.1134
  2. 10.1207/s15327914nc5002_11 · doi:10.1207/s15327914nc5002_11
  3. 1998, Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man, Mutat Res, 402, 165, 10.1016/S0027-5107(97)00294-7 · doi:10.1016/s0027-5107(97)00294-7
  4. 10.1093/carcin/14.11.2423 · doi:10.1093/carcin/14.11.2423
  5. 1994, Chemoprevention of respiratory-tract neoplasia in the hamster by oltipraz, alone and in combination, Int J Oncol, 4, 661
  6. 1996, Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz, Cancer Res, 56, 3395
  7. 2012, Genotype analysis of the NRF2 gene mutation in lung cancer, Int J Mol Med, 31, 1135
  8. 2000, Dietary intake of isothiocyanates: Evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk, Cancer Epidemiol Biomarkers Prev, 9, 1017

Cited by

See all 1,297

Metadata

Authors
Jaramillo, M. C., & Zhang, D. D.
Venue
Genes & Development
Published
2013-10-15
Volume
27
Issue
20
Pages
2179-2191
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2138271341
Cited by
1,297
References
137
Type
posted content
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.